BNP PARIBAS FINANCIAL MARKETS - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 1 filers reported holding IMMUNOMEDICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$321,073,000
-76.8%
3,776
-90.3%
0.00%
-100.0%
Q2 2020$1,383,081,000
+10.5%
39,026
-58.0%
0.00%
-33.3%
Q1 2020$1,251,739,000
+136.3%
92,859
+271.0%
0.00%
+200.0%
Q4 2019$529,677,000
+28.6%
25,032
-19.4%
0.00%0.0%
Q3 2019$411,988,000
+45.2%
31,070
+51.9%
0.00%0.0%
Q2 2019$283,780,000
-57.8%
20,460
-41.6%
0.00%0.0%
Q1 2019$672,849,000
+1132.4%
35,026
+815.5%
0.00%
Q4 2018$54,597,000
-68.2%
3,826
-53.6%
0.00%
Q3 2018$171,827,000
-2.0%
8,249
+11.4%
0.00%
Q2 2018$175,276,000
-44.7%
7,405
-65.9%
0.00%
-100.0%
Q1 2018$316,906,000
-8.7%
21,691
+1.0%
0.00%0.0%
Q4 2017$346,939,000
+140.7%
21,469
+108.2%
0.00%
Q3 2017$144,148,000
+48.1%
10,311
-6.4%
0.00%
Q2 2017$97,315,000
+2165.2%
11,021
+1559.8%
0.00%
Q1 2017$4,296,000
-79.0%
664
-88.1%
0.00%
Q4 2016$20,482,000
+3.3%
5,581
-8.5%
0.00%
Q3 2016$19,819,000
+140.5%
6,098
+71.7%
0.00%
Q2 2016$8,241,000
-86.1%
3,552
-81.7%
0.00%
Q4 2015$59,454,000
+53.5%
19,366
-14.0%
0.00%
Q3 2015$38,741,000
+18.9%
22,524
+180.7%
0.00%
Q2 2015$32,582,000
+336.7%
8,025
+312.0%
0.00%
Q1 2015$7,461,000
-58.8%
1,948
-60.0%
0.00%
Q3 2014$18,102,000
+2151.5%
4,866
+2447.6%
0.00%
Q1 2014$804,000
-82.8%
191
-81.2%
0.00%
Q4 2013$4,664,000
-96.3%
1,014
-95.0%
0.00%
Q3 2013$125,240,000
-25.7%
20,200
-34.8%
0.00%
Q2 2013$168,564,00030,9860.00%
Other shareholders
IMMUNOMEDICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
IFP Advisors, Inc 0$00.00%
View complete list of IMMUNOMEDICS INC shareholders